Previous Close | 1.2900 |
Open | 1.2200 |
Bid | 1.2600 x 3100 |
Ask | 1.2700 x 1000 |
Day's Range | 1.2100 - 1.2700 |
52 Week Range | 1.0300 - 31.4700 |
Volume | |
Avg. Volume | 271,830 |
Market Cap | 18.747M |
Beta (5Y Monthly) | 1.88 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.3570 |
Earnings Date | Sep 05, 2022 - Sep 09, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for FBRX
DALLAS, August 15, 2022--Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a biopharmaceutical company focused on autoimmune diseases, today announced second quarter 2022 results and provided a business update.
We can readily understand why investors are attracted to unprofitable companies. For example, although...
DALLAS, June 07, 2022--Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a biopharmaceutical company focused on autoimmune diseases today announced the issuance of an equity inducement award as required by the Nasdaq Stock Market Rules.